Results 1 to 10 of about 27,667 (182)

Acute generalized exanthematous pustulosis induced by duloxetine

open access: yesJEADV Clinical Practice, 2023
Duloxetine is a serotonin and norepinephrine reuptake inhibitor. Some rare duloxetine‐induced hypersensitivity skin reactions have been reported. We report a case of acute generalized exanthematous pustulosis potentially induced by duloxetine.
Numa Deydier   +8 more
doaj   +1 more source

Duloxetine hydrochloride [PDF]

open access: yesActa Crystallographica Section E Structure Reports Online, 2009
THE TITLE COMPOUND [SYSTEMATIC NAME: N-methyl-3-(1-naphth-yloxy)-3-(2-thien-yl)propan-1-aminium chloride], C(18)H(20)NOS(+)·Cl(-), was crystallized from 1,4-dioxane. Twofold rotational disorder exhibited by the thio-phene ring in a 0.580 (5):0.420 (5) ratio represents two different conformations of the mol-ecule that exist in the same crystal form. The
Mohan Bhadbhade   +4 more
openaire   +3 more sources

Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study

open access: yesDrugs - Real World Outcomes, 2022
Background Depression or depressive symptoms are common among pregnant women. The use of antidepressants during pregnancy has grown steadily. The risk of offspring being born small for gestational age or prematurely when exposed to duloxetine during ...
Mikkel Zöllner Ankarfeldt   +7 more
doaj   +1 more source

Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials [PDF]

open access: yes, 2020
It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties.
Hengartner, Michael Pascal   +3 more
core   +2 more sources

Sleep Dysfunction in Fibromyalgia and Therapeutic Approach Options [PDF]

open access: yes, 2020
Fibromyalgia, characterised by persistent pain, sleep disturbance, fatigue and cognitive dysfunction, is a central sensitivity syndrome that also involves abnormality in peripheral generators and in the hypothalamic pituitary adrenal axis.
Lawson, Kim
core   +1 more source

Preclinical discovery of duloxetine for the treatment of depression [PDF]

open access: yes, 2012
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most severely disabling mental disorders, and in many cases areIntroduction: Affective disorders, including major depressive disorder (MDD), are among the most ...
Berrocoso Domínguez, Esther María   +4 more
core   +2 more sources

Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice [PDF]

open access: yes, 2015
Poor micturition control may cause profound distress, because proper voiding is mandatory for an active social life. Micturition results from the subtle interplay of central and peripheral components.
Antonio, Caretta   +6 more
core   +4 more sources

The efficacy of duloxetine depends on spinal cholinergic plasticity in neuropathic pain model rats

open access: yesIBRO Neuroscience Reports, 2022
Antidepressants, such as duloxetine, are widely used to treat chronic pain, including neuropathic pain; however, their efficacy is unsatisfactory.
Daiki Kato   +3 more
doaj   +1 more source

Management of Widespread Pain and Fibromyalgia [PDF]

open access: yes, 2016
Peer reviewedPublisher ...
Basu, Neil   +2 more
core   +2 more sources

Rapid-Onset Hyponatremia Induced by Duloxetine in an Elderly Patient

open access: yesNeuropsychiatric Investigation, 2015
Duloxetine is a potent serotonin and noradrenaline re-uptake inhibitor that is used for the management of major depressive disorder and diabetic neuropathic pain. The common adverse effects are nausea, dry mouth, fatigue, dizziness, somnolence, anorexia,
Seden Demirci   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy